ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2023

Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real-World Propensity Score-Weighted Analysis.

Susanne Ibing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.